US Food and Drug Administration (USFDA) Archives - Page 4 of 7

Aurobindo Pharma Subsidiary’s Telangana Units Gets VAI Status from USFDA

Ali WaghbakriwalaJune 27, 2024June 27, 2024

by Ali WaghbakriwalaJune 27, 2024June 27, 202402997

Aurobindo Pharma subsidiary Eugia Pharma’s injectable plant in Telangana was classified by the US Food and Drug Administration (USFDA) in an establishment inspection report as...

BUSINESS

Shilpa Medicare Bio-Analytical Laboratory Cleared with Zero Observations

Ali WaghbakriwalaJune 25, 2024June 25, 2024

by Ali WaghbakriwalaJune 25, 2024June 25, 20242 2246

Shilpa Medicare, on Tuesday, 25 June, announced that the US Food and Drug Administration (FDA) has successfully concluded an inspection of the company’s Bio-Analytical Laboratory,...

MARKETS

Lupin Shares Gain 1.8% as Somerset Facility Receives VAI Status from USFDA

Ali WaghbakriwalaJune 24, 2024June 24, 2024

by Ali WaghbakriwalaJune 24, 2024June 24, 202411684

Shares of Lupin Ltd. were trading in the green and 1.8% higher on 21 June after the company’s manufacturing facility in Somerset, New Jersey, received...

MARKETS

Wanbury Shares Shot-Up 5% as USFDA Issues 0 Observations

Ali WaghbakriwalaJune 20, 2024June 20, 2024

by Ali WaghbakriwalaJune 20, 2024June 20, 202413196

Shares of Wanbury Ltd were trading in the green and 5% higher on 20 June after the US Food and Drug Administration (USFDA) issued zero...

MARKETS

Zydus Lifesciences Shares Slump 3% as Gujarat Unit Receives OAI Status

Ali WaghbakriwalaJune 18, 2024June 18, 2024

by Ali WaghbakriwalaJune 18, 2024June 18, 20241950

Shares of Zydus Lifesciences Ltd were trading in the red and 3% lower on 18 June after the company’s injectable manufacturing facility in Ahmedabad, Gujarat...

MARKETS

Aurobindo Pharma Shares Slump 3% as Telangana Facility Gets OAI Classification

Ali WaghbakriwalaMay 27, 2024May 27, 2024

by Ali WaghbakriwalaMay 27, 2024May 27, 202401169

Shares of Aurobindo Pharma slumped 3% on 27 May after the company’s Telangana facility received an Official Action Indicated classification from the US Food and Drug...

BUSINESS

Lupin’s Facility Gers Six Observations From the USFDA

Ali WaghbakriwalaMay 20, 2024May 20, 2024

by Ali WaghbakriwalaMay 20, 2024May 20, 20242 1776

Lupin Limited announced that its facility in the US received six observations. In its regulatory filing, the company said that the US Food and Drug...

BUSINESS

Sun Pharma, Dr Reddy’s, and Aurobindo Pharma Recall Products in the US

Ali WaghbakriwalaMay 20, 2024May 20, 2024

by Ali WaghbakriwalaMay 20, 2024May 20, 202401955

Drug manufacturers Sun Pharma, Dr Reddy’s, and Aurobindo Pharma are recalling their products in the United States of America market due to manufacturing issues, according to...

MARKETS

Glenmark Pharmaceuticals Shares Gain 1% on Receiving USFDA Approval

Ali WaghbakriwalaMay 17, 2024May 17, 2024

by Ali WaghbakriwalaMay 17, 2024May 17, 202412412

The shares of Glenmark Pharmaceuticals Ltd were trading in the green and 1% higher on 17 May after the company announced receiving final approval from the...

MARKETS

Granules Shares Gain 2% on USFDA Approval

Ali WaghbakriwalaApril 30, 2024April 30, 2024

by Ali WaghbakriwalaApril 30, 2024April 30, 202402458

Shares of Granules India Ltd were trading 2% higher on 30 April after it announced receiving approval from the US health authorities to market a...

Download Unicorn Signals App

EquityPandit

Tag : US Food and Drug Administration (USFDA)

Aurobindo Pharma Subsidiary’s Telangana Units Gets VAI Status from USFDA

Shilpa Medicare Bio-Analytical Laboratory Cleared with Zero Observations

Lupin Shares Gain 1.8% as Somerset Facility Receives VAI Status from USFDA

Wanbury Shares Shot-Up 5% as USFDA Issues 0 Observations

Zydus Lifesciences Shares Slump 3% as Gujarat Unit Receives OAI Status

Aurobindo Pharma Shares Slump 3% as Telangana Facility Gets OAI Classification

Lupin’s Facility Gers Six Observations From the USFDA

Sun Pharma, Dr Reddy’s, and Aurobindo Pharma Recall Products in the US

Glenmark Pharmaceuticals Shares Gain 1% on Receiving USFDA Approval

Granules Shares Gain 2% on USFDA Approval

EquityPandit